These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38983042)
1. Outcomes of the addition of oral administration of curcumin-phospholipid to hyaluronic acid-based tear substitute for the treatment of dry eye disease. Borselli M; Ferrari FF; Bianchi P; Rossi C; Scalzo GC; Mangialavori D; Scorcia V; Giannaccare G Front Ophthalmol (Lausanne); 2023; 3():1236525. PubMed ID: 38983042 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments. Fogagnolo P; Giannaccare G; Mencucci R; Villani E; Orfeo V; Aragona P; Ophthalmol Ther; 2024 Jan; 13(1):251-266. PubMed ID: 37948015 [TBL] [Abstract][Full Text] [Related]
4. Preoperative dry eyes disease in cataract patients with deficient tear break up time: evaluation of OSDI questionnaire, its subcategories and Keratograph 5M device results. Fydanaki O; Chalkiadaki E; Tsiogka A; Gartaganis PS; Karmiris E Int Ophthalmol; 2022 Oct; 42(10):3017-3025. PubMed ID: 35394587 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of meibomian gland dysfunction in type 2 diabetes with dry eye disease: a non-randomized controlled trial. Yang Q; Liu L; Li J; Yan H; Cai H; Sheng M; Li B BMC Ophthalmol; 2023 Jan; 23(1):44. PubMed ID: 36721131 [TBL] [Abstract][Full Text] [Related]
12. A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial. Gioia N; Gerson J; Ryan R; Barbour K; Poteet J; Jennings B; Sharp M; Lowery R; Wilson J; Morde A; Rai D; Padigaru M; Periman LM Front Ophthalmol (Lausanne); 2024; 4():1362113. PubMed ID: 38984118 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Tear Function Outcomes following Collagen Cross-Linking Treatment in Ectatic Corneas. Wang X; Bai X; Jin C; Zhao L; Wei R J Ophthalmol; 2022; 2022():1910607. PubMed ID: 35321348 [TBL] [Abstract][Full Text] [Related]
14. Correlation of Measures From the OCULUS Keratograph and Clinical Assessments of Dry Eye Disease in the Dry Eye Assessment and Management Study. Sutphin JE; Ying GS; Bunya VY; Yu Y; Lin MC; McWilliams K; Schmucker E; Kuklinski EJ; Asbell PA; Maguire MG; Cornea; 2022 Jul; 41(7):845-851. PubMed ID: 34294637 [TBL] [Abstract][Full Text] [Related]
15. Prospective randomized study to evaluate the efficacy and tolerability of Ectoin® containing Eye Spray (EES09) and comparison to the liposomal Eye Spray Tears Again® (TA) in the treatment of dry eye disease. Nosch DS; Joos RE; Job M Cont Lens Anterior Eye; 2021 Jun; 44(3):101318. PubMed ID: 32354652 [TBL] [Abstract][Full Text] [Related]
16. Analysis of Ocular Surface Characteristics and Incidence of Dry Eye Disease in Systemic Lupus Erythematosus Patients Without Secondary Sjögren's Syndrome. Gu Z; Lu Q; Zhang A; Shuai ZW; Liao R Front Med (Lausanne); 2022; 9():833995. PubMed ID: 35355597 [TBL] [Abstract][Full Text] [Related]
17. Assessment of condition-induced changes on the ocular surface using novel methods to assess the tear film dynamics and the lipid layer. Vicente García-Marqués J; Talens-Estarelles C; García-Lázaro S; Cerviño A Cont Lens Anterior Eye; 2023 Jun; 46(3):101799. PubMed ID: 36577612 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Each Eye According to the Order of Noninvasive Keratographic Tear Film Evaluation. Shin H; Jung S; Jung JW Korean J Ophthalmol; 2023 Jun; 37(3):230-235. PubMed ID: 37309556 [TBL] [Abstract][Full Text] [Related]
19. A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease. Deinema LA; Vingrys AJ; Wong CY; Jackson DC; Chinnery HR; Downie LE Ophthalmology; 2017 Jan; 124(1):43-52. PubMed ID: 27817918 [TBL] [Abstract][Full Text] [Related]
20. Alterations of Ocular Surface and Tear Film in Patients with Obstructive Sleep Apnea/Hypopnea Syndrome. Lin PW; Lin HC; Chang CT; Friedman M; Salapatas AM; Lin MC; Lin CY Nat Sci Sleep; 2022; 14():277-290. PubMed ID: 35450223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]